We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $999B
1-Year Est. Return 46.22%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+0.76%
1 Year Est. Return
+46.22%
3 Year Est. Return
+150.45%
5 Year Est. Return
+185.95%
10 Year Est. Return
+1,389.53%
AUM
$706B
AUM Growth
-$5.71B
Cap. Flow
-$2.17B
Cap. Flow %
-0.31%
Top 10 Hldgs %
21.49%
Holding
2,592
New
52
Increased
1,566
Reduced
801
Closed
74

Sector Composition

Rank Sector Weight
1 Technology 20.27%
2 Healthcare 16.18%
3 Financials 13.98%
4 Consumer Discretionary 13.5%
5 Industrials 10.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IFFT
1176
DELISTED
International Flavors & Fragrances Inc. 6.00% Tangible Equity Units
IFFT
$18.5M ﹤0.01%
392,042
+6,365
+2% +$311K
IPGP icon
1177
IPG Photonics
IPGP
$3.63B
$18.4M ﹤0.01%
135,756
+18,636
+16% +$2.47M
LBRDA icon
1178
Liberty Broadband Class A
LBRDA
$5.25B
$18.4M ﹤0.01%
176,031
+103
+0.1% +$10.6K
EMN icon
1179
Eastman Chemical
EMN
$8.46B
$18.4M ﹤0.01%
248,782
-6,911
-3% -$496K
DRNA
1180
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$18.3M ﹤0.01%
1,276,912
+123,913
+11% +$1.77M
IPG
1181
DELISTED
Interpublic Group of Companies
IPG
$18.3M ﹤0.01%
848,862
+1,955
+0.2% +$42.2K
GNMK
1182
DELISTED
GenMark Diagnostics, Inc
GNMK
$18.2M ﹤0.01%
3,000,151
-3,589,340
-54% -$22.4M
WU icon
1183
Western Union
WU
$2.3B
$18.1M ﹤0.01%
780,250
-291
-0% -$6.28K
WVE icon
1184
Wave Life Sciences
WVE
$1.03B
$18M ﹤0.01%
877,644
-216,369
-20% -$4.96M
TECD
1185
DELISTED
Tech Data Corp
TECD
$18M ﹤0.01%
172,580
+10,063
+6% +$981K
IVV icon
1186
iShares Core S&P 500 ETF
IVV
$909B
$17.9M ﹤0.01%
60,049
-15,645
-21% -$4.65M
MCRN
1187
DELISTED
Milacron Holdings Corp.
MCRN
$17.9M ﹤0.01%
1,073,179
-8,562
-0.8% -$138K
MRO
1188
DELISTED
Marathon Oil Corporation
MRO
$17.9M ﹤0.01%
1,454,971
-59,683
-4% -$772K
ASIX icon
1189
AdvanSix
ASIX
$453M
$17.9M ﹤0.01%
694,038
-14,716
-2% -$358K
WHR icon
1190
Whirlpool
WHR
$2.73B
$17.8M ﹤0.01%
112,658
-3,718
-3% -$534K
PHM icon
1191
Pultegroup
PHM
$24.7B
$17.8M ﹤0.01%
486,572
-4,892
-1% -$163K
MTG icon
1192
MGIC Investment
MTG
$6.34B
$17.6M ﹤0.01%
1,395,690
-16,832
-1% -$217K
TENB icon
1193
Tenable Holdings
TENB
$4.24B
$17.4M ﹤0.01%
778,484
+463,146
+147% +$11.7M
URI icon
1194
United Rentals
URI
$71.9B
$17.4M ﹤0.01%
139,406
-1,158
-0.8% -$140K
FSS icon
1195
Federal Signal
FSS
$7.61B
$17.4M ﹤0.01%
530,571
+1,265
+0.2% +$37.6K
FUL icon
1196
H.B. Fuller
FUL
$3.32B
$17.3M ﹤0.01%
371,406
+353,612
+1,987% +$16.2M
SGA icon
1197
Saga Communications
SGA
$60.5M
$17.2M ﹤0.01%
579,559
-49,396
-8% -$1.48M
TNDM icon
1198
Tandem Diabetes Care
TNDM
$1.58B
$17.2M ﹤0.01%
291,417
+22,506
+8% +$1.44M
QRVO icon
1199
Qorvo
QRVO
$8.65B
$16.9M ﹤0.01%
227,463
-2,151
-0.9% -$156K
DISCK
1200
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$16.8M ﹤0.01%
683,081
-3,567
-0.5% -$96.4K

Similar funds

T. Rowe Price Associates's Q3 2019 Portfolio in Review

As of Q3 2019, T. Rowe Price Associates held 2,592 positions worth $706B, down 0.8% from $712B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Trading was light in Q3 2019: portfolio turnover was 4.9%. T. Rowe Price Associates opened 52 new positions and exited 74, leaving the 2,592-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q3 2019 buy was The Southern Company: 9,440,159 shares worth $502M.
  • T. Rowe Price Associates added most to Fidelity National Information Services in Q3 2019, an estimated $3.15B increase.
  • T. Rowe Price Associates's biggest Q3 2019 reduction was Bank of America, cutting an estimated $1.43B.
  • T. Rowe Price Associates fully exited Worldpay, Inc. in Q3 2019, selling an estimated $3.23B.
  • T. Rowe Price Associates's ten largest holdings make up 21% of its $706B portfolio in Q3 2019.
  • T. Rowe Price Associates opened 52 new positions and closed 74 in Q3 2019.
  • T. Rowe Price Associates's portfolio value fell 0.8% quarter-over-quarter to $706B.

Based on T. Rowe Price Associates's 13F filing for Q3 2019, filed 14 Nov 2019.